Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachael F Grace

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Seminars in Hematology|May 14, 2013
Standardized clinical assessment and management plans (SCAMPs): perspectives on a new method to understand treatment decisions and outcomes in immune thrombocytopeniaRachael F Grace
Hematology. American Society of Hematology. Education Program|December 9, 2023
Pyruvate kinase activators for treatment of pyruvate kinase deficiencyRachael F Grace
Pediatric Clinics of North America|May 28, 2018
Red Blood Cell Enzyme DisordersRachael F Grace, Bertil Glader
Blood|July 24, 2020
Management of pyruvate kinase deficiency in children and adultsRachael F Grace, Wilma Barcellini
Hematology. American Society of Hematology. Education Program|December 4, 2016
Second-line therapies in immune thrombocytopeniaRachael F Grace, Cindy Neunert
Lancet (London, England)|August 2, 2015
Thrombopoietin-receptor agonists in children with immune thrombocytopeniaCindy E Neunert, Rachael F Grace
Hematology/Oncology Clinics of North America|April 30, 2019
Pediatric HematologyRachael F Grace, Russell E Ware
Blood|September 3, 2021
An update on pediatric ITP: differentiating primary ITP, IPD, and PIDRachael F Grace, Michele P Lambert
Blood|August 8, 2020
Pyruvate kinase deficiency in a newborn with extramedullary hematopoiesis in the skinRichard A Voit, Rachael F Grace
Pediatric Blood & Cancer|December 28, 2021
Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trialsNardeen Ayad, Rachael F Grace, Hanny Al-Samkari
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Seminars in Hematology|May 14, 2013
Standardized clinical assessment and management plans (SCAMPs): perspectives on a new method to understand treatment decisions and outcomes in immune thrombocytopeniaRachael F Grace
Hematology. American Society of Hematology. Education Program|December 9, 2023
Pyruvate kinase activators for treatment of pyruvate kinase deficiencyRachael F Grace
Pediatric Clinics of North America|May 28, 2018
Red Blood Cell Enzyme DisordersRachael F Grace, Bertil Glader
Blood|July 24, 2020
Management of pyruvate kinase deficiency in children and adultsRachael F Grace, Wilma Barcellini
Hematology. American Society of Hematology. Education Program|December 4, 2016
Second-line therapies in immune thrombocytopeniaRachael F Grace, Cindy Neunert
Lancet (London, England)|August 2, 2015
Thrombopoietin-receptor agonists in children with immune thrombocytopeniaCindy E Neunert, Rachael F Grace
Hematology/Oncology Clinics of North America|April 30, 2019
Pediatric HematologyRachael F Grace, Russell E Ware
Blood|September 3, 2021
An update on pediatric ITP: differentiating primary ITP, IPD, and PIDRachael F Grace, Michele P Lambert
Blood|August 8, 2020
Pyruvate kinase deficiency in a newborn with extramedullary hematopoiesis in the skinRichard A Voit, Rachael F Grace
Pediatric Blood & Cancer|December 28, 2021
Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trialsNardeen Ayad, Rachael F Grace, Hanny Al-Samkari
Pageof 11